+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell & Gene Therapy Clinical Trials Market by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Vector Type (Non-Viral Vector, Viral Vector), Cell Type, Indication, Trial Phase - Global Forecast 2025-2030- Product Image
Cell & Gene Therapy Clinical Trials Market by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Vector Type (Non-Viral Vector, Viral Vector), Cell Type, Indication, Trial Phase - Global Forecast 2025-2030- Product Image
Sale

Cell & Gene Therapy Clinical Trials Market by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Vector Type (Non-Viral Vector, Viral Vector), Cell Type, Indication, Trial Phase - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666050
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell & Gene Therapy Clinical Trials Market is undergoing rapid transformation as advancing therapeutic platforms, regulatory milestones, and supply chain adaptations shape the clinical trials landscape. Senior stakeholders require actionable intelligence to navigate this evolving environment and make strategic investment decisions with confidence.

Market Snapshot: Cell & Gene Therapy Clinical Trials Market Growth

The Cell & Gene Therapy Clinical Trials Market grew from USD 10.48 billion in 2024 to USD 12.08 billion in 2025, continuing at a CAGR of 14.76% to reach USD 23.95 billion by 2030. This sustained expansion reflects increasing global adoption of advanced cell-based and genetic therapies targeting a diverse range of conditions. Fueled by venture funding, regulatory pathways, and collaborative partnerships, clinical research initiatives in this field are driving notable growth and innovation.

Scope & Segmentation: Comprehensive Coverage of Market Dynamics

This report offers a thorough examination of the Cell & Gene Therapy Clinical Trials Market, with segmentation and analysis designed for precise strategic planning. Covered areas include:

  • Therapy Types: Cell Therapy (CAR T Cell, Dendritic Cell Therapy, NK Cell Therapy, Stem Cell Therapy), Gene Therapy (Non-Viral Vector: Electroporation, Lipid Nanoparticle, Naked DNA/RNA; Viral Vector: Adeno-Associated Virus, Adenoviral, Retroviral), Tissue Engineered Products
  • Vector Types: Non-Viral (Electroporation, Lipid Nanoparticle, Naked DNA/RNA), Viral (Adeno-Associated Virus, Adenoviral, Retroviral)
  • Cell Types: Dendritic Cell, NK Cell, Stem Cell (Hematopoietic, Mesenchymal), T Cell (CAR T, TCR)
  • Indications: Neurology (Alzheimer Disease, Parkinson Disease), Oncology (Hematologic Cancer: Leukemia, Lymphoma; Solid Tumor: Breast Cancer, Melanoma), Rare Diseases (Genetic Disorders: Cystic Fibrosis, Hemophilia; Metabolic Disorders)
  • Trial Phases: Phase I, II, III
  • Regions: Americas (US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, UAE, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, among others)
  • Leading Companies: Novartis AG, Gilead Sciences, Spark Therapeutics, bluebird bio, Sangamo Therapeutics, CRISPR Therapeutics, Editas Medicine, Fate Therapeutics, Orchard Therapeutics, uniQure N.V.

Key Takeaways for Senior Decision-Makers

  • Emerging therapeutic modalities and delivery technologies are expanding trial activity beyond traditional genetic disorders into fields such as neurology and oncology.
  • Recent regulatory developments streamline timelines for early-phase studies and clarify technical requirements, attracting both established pharmaceutical groups and innovative biotechnology companies.
  • Manufacturing innovations, including modular production and digital process analytics, enable trial sponsors to pivot between different product platforms efficiently, thereby mitigating operational risks.
  • Geographical trends indicate that competitive advantages vary by region, with the Americas leveraging funding and infrastructure, EMEA offering diverse patient pools, and Asia-Pacific accelerating through proactive government incentives.
  • Collaborations among contract manufacturers, academic centers, and sponsors are integral to rapid scale-up and risk-sharing, especially as new challenges emerge and adaptive trial designs become prevalent.

Tariff Impact: U.S. Measures Reshape Costs and Sourcing Strategies

United States tariffs introduced in 2025 have introduced heightened cost pressures across the cell and gene therapy supply chain, affecting raw material imports and prompting shifts in procurement and logistics. Sponsors are reevaluating sourcing strategies, from seeking domestic alternatives to balancing nearshoring and international expertise. While these measures pose immediate operational challenges, they also drive regional investment in manufacturing capacity and promote supply chain resilience. Stakeholders are actively exploring partnerships and diversification to safeguard clinical trial progression against regulatory uncertainties.

Methodology & Data Sources

The report utilizes extensive secondary research alongside primary interviews with clinical investigators, manufacturing leaders, regulators, and technology providers. Data was cross-validated through regulatory filings, scientific literature, patent analysis, and expert consultations to ensure accuracy and reliability of insights.

Why This Report Matters

  • Supports strategic planning with detailed segmentation and competitor benchmarking across all major regions and modalities in the Cell & Gene Therapy Clinical Trials Market.
  • Equips decision-makers with timely analysis of supply chain, regulatory, and partnership dynamics relevant to investment optimization and risk mitigation.

Conclusion

This report delivers a rigorous overview of the clinical trial landscape, actionable segmentation, and emerging trends shaping the future of cellular and gene therapies. Use these insights to benchmark your investments and align your strategy with evolving market realities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of allogeneic CAR-T therapies targeting solid tumors with off-the-shelf solutions
5.2. Integration of gene editing tools like base editing to increase safety in hemophilia trials
5.3. Adoption of next-generation viral vectors to improve transduction efficiency in T-cell therapies
5.4. Development of non-viral delivery platforms for in vivo gene therapies to reduce immunogenicity
5.5. Implementation of decentralized manufacturing models to scale cell therapy production globally
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell & Gene Therapy Clinical Trials Market, by Therapy Type
8.1. Introduction
8.2. Cell Therapy
8.2.1. CAR T Cell
8.2.2. Dendritic Cell Therapy
8.2.3. NK Cell Therapy
8.2.4. Stem Cell Therapy
8.3. Gene Therapy
8.3.1. Non-Viral Vector
8.3.1.1. Electroporation
8.3.1.2. Lipid Nanoparticle
8.3.1.3. Naked DNA/RNA
8.3.2. Viral Vector
8.3.2.1. Adeno-Associated Virus
8.3.2.2. Adenoviral
8.3.2.3. Retroviral
8.4. Tissue Engineered Products
9. Cell & Gene Therapy Clinical Trials Market, by Vector Type
9.1. Introduction
9.2. Non-Viral Vector
9.2.1. Electroporation
9.2.2. Lipid Nanoparticle
9.2.3. Naked DNA/RNA
9.3. Viral Vector
9.3.1. Adeno-Associated Virus
9.3.2. Adenoviral
9.3.3. Retroviral
10. Cell & Gene Therapy Clinical Trials Market, by Cell Type
10.1. Introduction
10.2. Dendritic Cell
10.3. NK Cell
10.4. Stem Cell
10.4.1. Hematopoietic Stem Cell
10.4.2. Mesenchymal Stem Cell
10.5. T Cell
10.5.1. CAR T
10.5.2. TCR
11. Cell & Gene Therapy Clinical Trials Market, by Indication
11.1. Introduction
11.2. Neurology
11.2.1. Alzheimer Disease
11.2.2. Parkinson Disease
11.3. Oncology
11.3.1. Hematologic Cancer
11.3.1.1. Leukemia
11.3.1.2. Lymphoma
11.3.2. Solid Tumor
11.3.2.1. Breast Cancer
11.3.2.2. Melanoma
11.4. Rare Disease
11.4.1. Genetic Disorder
11.4.1.1. Cystic Fibrosis
11.4.1.2. Hemophilia
11.4.2. Metabolic Disorder
12. Cell & Gene Therapy Clinical Trials Market, by Trial Phase
12.1. Introduction
12.2. Phase I
12.3. Phase II
12.4. Phase III
13. Americas Cell & Gene Therapy Clinical Trials Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cell & Gene Therapy Clinical Trials Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cell & Gene Therapy Clinical Trials Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Gilead Sciences, Inc.
16.3.3. Spark Therapeutics, Inc.
16.3.4. bluebird bio, Inc.
16.3.5. Sangamo Therapeutics, Inc.
16.3.6. CRISPR Therapeutics AG
16.3.7. Editas Medicine, Inc.
16.3.8. Fate Therapeutics, Inc.
16.3.9. Orchard Therapeutics Ltd
16.3.10. uniQure N.V.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL & GENE THERAPY CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL & GENE THERAPY CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL & GENE THERAPY CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CELL & GENE THERAPY CLINICAL TRIALS MARKET: RESEARCHAI
FIGURE 26. CELL & GENE THERAPY CLINICAL TRIALS MARKET: RESEARCHSTATISTICS
FIGURE 27. CELL & GENE THERAPY CLINICAL TRIALS MARKET: RESEARCHCONTACTS
FIGURE 28. CELL & GENE THERAPY CLINICAL TRIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL & GENE THERAPY CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CAR T CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CAR T CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NK CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NK CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NAKED DNA/RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NAKED DNA/RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENOVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENOVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RETROVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RETROVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TISSUE ENGINEERED PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TISSUE ENGINEERED PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NAKED DNA/RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NAKED DNA/RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENOVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ADENOVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RETROVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RETROVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DENDRITIC CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DENDRITIC CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NK CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NK CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MESENCHYMAL STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MESENCHYMAL STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CAR T, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CAR T, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 225. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 226. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 227. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 228. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 229. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 230. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 231. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 232. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 233. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 234. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 235. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 237. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 238. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 239. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 240. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 241. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 242. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 243. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2018-2024 (USD MILLION)
TABLE 244. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2025-2030 (USD MILLION)
TABLE 245. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2018-2024 (USD MILLION)
TABLE 246. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2025-2030 (USD MILLION)
TABLE 247. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 250. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 251. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2018-2024 (USD MILLION)
TABLE 254. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2025-2030 (USD MILLION)
TABLE 255. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 256. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 257. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 258. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 259. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2018-2024 (USD MILLION)
TABLE 260. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER, 2025-2030 (USD MILLION)
TABLE 261. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 262. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 270. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 271. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 272. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 273. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 274. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 275. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 276. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NON-VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 277. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 278. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 279. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 280. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 281. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2018-2024 (USD MILLION)
TABLE 282. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STEM CELL, 2025-2030 (USD MILLION)
TABLE 283. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2018-2024 (USD MILLION)
TABLE 284. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY T CELL, 2025-2030 (USD MILLION)
TABLE 285. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 288. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 289. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 290. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 291. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2018-2024 (USD MILLION)
TABLE 292. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC CANCER, 2025-2030 (USD MILLION)
TABLE 29

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell & Gene Therapy Clinical Trials market report include:
  • Novartis AG
  • Gilead Sciences, Inc.
  • Spark Therapeutics, Inc.
  • bluebird bio, Inc.
  • Sangamo Therapeutics, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • Fate Therapeutics, Inc.
  • Orchard Therapeutics Ltd
  • uniQure N.V.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.95 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cancer Gene Therapy Market by Vector Type (Nonviral Vectors, Viral Vectors), Therapy Type (Ex Vivo, In Vivo), Indication, Stage, End User - Global Forecast 2025-2030 - Product Image

Cancer Gene Therapy Market by Vector Type (Nonviral Vectors, Viral Vectors), Therapy Type (Ex Vivo, In Vivo), Indication, Stage, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Gene Therapy Market by Vector Type (Non-Viral Vectors, Viral Vectors), Treatment Modality (Germline Therapy, Somatic Cell Therapy), Target Genome, Delivery Mode, Route of Administration, Patient Type, Therapeutic Area, End-User - Global Forecast 2025-2030 - Product Image

Gene Therapy Market by Vector Type (Non-Viral Vectors, Viral Vectors), Treatment Modality (Germline Therapy, Somatic Cell Therapy), Target Genome, Delivery Mode, Route of Administration, Patient Type, Therapeutic Area, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Gene Therapy Market Outlook to 2029 - Product Image

Gene Therapy Market Outlook to 2029

  • Report
  • 83 Pages
  • Global
From
Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast - Product Image

Gene Therapy Market, 6th Edition: Industry Trends and Global Forecasts to 2035 - Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.